Ovid Therapeutics Inc. (OVID) — Revenue

Annual figures by fiscal year, from SEC filings.

2021: $208.38M2022: $1.50M2023: $392.0K2024: $566.0K2025: $7.25M$7.25M
2021Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$7.25M+1181.3%
2024$566.0K+44.4%
2023$392.0K-73.9%
2022$1.50M-99.3%
2021$208.38M